Serum metallothionein in newly diagnosed patients with childhood solid tumours
| Authors | |
|---|---|
| Year of publication | 2010 |
| Type | Article in Periodical |
| Magazine / Source | Acta Biochimica Polonica |
| MU Faculty or unit | |
| Citation | |
| Field | Biochemistry |
| Keywords | metallothionein; cancer; serum; Brdicka reaction; marker |
| Description | Tumour markers are substances produced by malignant cells or by the organism as a response to cancer development. Determination of their levels can, therefore, be used to monitor the risk, presence and prognosis of a cancer disease or to monitor the therapeutic response or early detection of residual disease.Results found in this work indicate that the MT level in blood serum can be considered as a promising marker for diagnostics, prognosis and estimation of therapy efficiency of childhood tumours. |
| Related projects: |